Fluorinated azole anticancer drugs: Synthesis,elaborated structure elucidation and docking studies

The present article deals with the synthesis of novel nano-sized fluorinated thiazoles and studying their anticancer potentiality. The targeted azoles could be accessed via trifluoro-methylated thiosemicarbazone (3) prepared by reaction of with thiosemicarbazide in acidic solution of ethanol. The latter a fluorinated building block (3) have been reacted with appropriate derivatives of a-halo compounds namely, N-aryl 2-oxopropane-hydrazonoyl chlorides 4a-f using dioxane containing TEA as base catalyst. Also, the reaction between N-(4-(1-(2-carbamothioylhydrazineylidene)ethyl)phenyl)-2,2,2-trifluoroacetamide (3) and chloroacetonitrile 8 under the same experimental conditions furnished the corresponding amino thiazole derivative 11. In the same manner the base catalyzed cyclocondensation reaction between N-(4-(1-(2-carbamothioylhydrazineylidene)ethyl)phenyl)-2,2,2-trifluoroacetamide (3) and phenacyl bromide derivatives 12a-d afforded the corresponding thiazoles 13a-d in good yield. The structure of all synthesized thiazole derivatives as well as their mechanistic pathways were studied based on spectral data analysis and physical characteristics. The nanosized products were confirmed by using XRD analysis. Moreover, twelve samples were submitted for evaluation of their cytotoxicity activities against MDA-MB-231 (breast cancer cell) using colorimetric MTT assay, in comparison with Cisplatin standard drug. Two nano-sized thiosemicarbazone derivative 3 and the thiazole derivative 7c showed potent activity with IC₅₀ = 7.7 and 2.97 µg/ml, respectively in compared with the IC₅₀ = 4.33 µg/ml of cisplatin. The nanosized thiazole derivative 7c was more potent than cisplatin. Also, two thiazole derivatives 13b and 7b showed good activity with IC₅₀ = 13.4 and 14.9 µg/ml. In addition, the molecular docking studies have been achieved using 4hy0, (X-chromosome-linked- inhibitor of apoptosis protein; (XIAP)).     

Screening of anti-inflammatory and antioxidant potential of functionalized tetrahydrocarbazole linked 1,2-diazoles and their docking studies

Inflammatory diseases are associated with life-threatening syndromes like hepatitis, cancer, and trauma injury while some decrease the quality of life such as rheumatism, arthritis, and tuberculosis. 1,2-Diazoles (pyrazolines) play a vital role in COX-2 inhibition thus dinitro-tetrahydrocarbazole linked pyrazolines have been synthesized and endeavor to screen for anti-inflammatory, antioxidant and molecular docking studies. For this purpose, 6,8-dinitro-acetyl-2,3,4,9-tetrahydrocarbazole (I), aromatic aldehydes (IIa-e) and hydrazines (IIIa-b) were combined via multicomponent reaction approach under the influence of microwave irradiations to afford pyrazolines (1–10). All new molecules were screened for in vitro anti-inflammatory activity by human red blood cells membrane stabilization, antioxidant potential by2,2-diphenyl-1-picrylhydrazyl,2,2´-azinobis (3-ethylbenzo thiazoline)-6-sulphonic acid, lipid peroxidation, and total antioxidant capacity assays along with cytotoxicity by brine shrimp lethality assay. Molecular docking was performed by using the Auto Dock program. Both disubstituted and trisubstituted diazoles showed excellent membrane stabilizing effects, (91.89 % and 77 %, respectively). The presence of phenol, furan, thiocarbamide, and chloro-moieties have the most prominent effect. Toxicity results indicated that compounds were less toxic at the tested dose (0.1 mg/ml). The antioxidant study showed that compound 2 was more active showing low IC₅₀ values (32.2 and 39.2 µg/ml) in DPPH and total phenolic contents assays respectively. Compound 3 (44.0 µg/ml) showed the highest potential assay in ABTS radical neutralization assay while compound 7 (65.0 µg/ml) showed maximum potential in lipid peroxidation. All diazoles (1–10) were screened for in vitro anti-inflammatory potential where disubstituted diazoles were found better than trisubstituted analogs and exhibited significant antioxidant potential. Molecular docking of diazoles showed a good correlation of their anti-inflammatory activity with p38α MAPK, COX-2, and 5-LOX enzymes that are molecular therapeutic targets of inflammation.     

中间相Si-Cu合金作为锂离子电池负极材料的第一性原理研究

采用第一性原理平面波赝势法,对中间相Si-Cu合金作为锂离子电池负极材料的嵌脱锂机理进行研究.结果表明,4个Si-Cu合金相中Si0.125Cu0.875合金相具有最低的体积膨胀系数及最低的嵌锂电位,导电性在4个合金相中排第二位,具有最佳的电化学综合性能.     

Synthesis,electrolyte properties and solar cell performance of hyperbranched poly(aryl-ether-urea)s

Hyperbranched poly(aryl-ether-urea)s with phenyl, N,N-dimethylamino ethyl and polyethylene oxide end-groups linked through urethane group – HBPEU-1, HBPEU-2 and HBPEU-3 respectively – were synthesized from an AB₂-type blocked isocyanate monomer and characterized by FT-IR, ¹H-NMR, SEC-MALLS, TGA and DSC techniques. The molecular weight of the polymers were found to be ranged from 4.9 × 10³ ? 1.96 × 10⁴ g/mol. The TGA results showed that the polymers decompose between 175°C – 220°C. In the DSC curves, HBPEU-1 and HBPEU-3 showed T_g at 160°C and 53°C respectively, whereas HBPEU-2 did not showed clear T_g. All the three polymers were converted into polymer electrolytes by doping with LiI/I₂. The doped polymers showed remarkably high ionic conductivity, up to 222 – 277 times compared to the un-doped polymers and the highest conductivity was observed with doped HBPEU-2. The TiO₂ based dye-sensitized solar cells (DSSCs) were fabricated using the doped polymer electrolytes and their performance was tested; HBPEU-2 showed good performance by yielding energy conversion efficiency (η) of 4.5%.     

催化剂活性位本质和构效关系的模型催化研究

明确催化剂的活性位本质和构建多相催化的结构和反应性能之间的准确关系是催化基础研究的重点,表面科学研究基于丰富的表征测试手段能够较好地在分子原子水平测定表面结构以明确催化剂活性位本质,并通过高压原位反应池测定相关催化反应性能,获得较可靠的催化剂构效关系。本文简要总结了近年来本人参与的几个模型催化研究例子,包括贵金属表面上CO和烷烃催化氧化的活性表面、纳米Au膜的制备和CO氧化的催化活性位、VO_x/Pt(111)上丙烷氧化的协同作用、Au Pd合金上醋酸乙烯酯合成Au的助催化作用、模型氧化物上纳米Pt的庚烷脱氢环化制甲苯的粒径关系等,以及相关模型催化研究技术的进展。     

Design,synthesis and theoretical analysis of functionalized dicarboxylate moieties based on organotin(IV) dinuclear complexes: crystal structure elucidation and biological studies

Dinuclear tin(IV) dicarboxylate complexes of the types [(n-Bu)₂Sn(oda)(4-pic)]₂·2H₂O (1) and [(n-Bu)₂Sn(pda)(H₂O)]₂ (2) [H₂oda = oxydiacetic acid; H₂pda = pyridine 2,6-dicarboxylic acid) were synthesized and characterized via physicochemical and spectroscopic studies. The spectroscopic results indicated that Sn is seven-coordinate having pentagonal bipyramidal (pbp) geometry in both complexes. The X-ray study of complex 2 further specified pentagonal bipyramidal geometry with dinuclear structural arrangement due to the involvement of carboxylate bridges formed by pda^2? moiety. The crystal structure is further stabilized by different weak interactions viz., C–C?H, C–C?O, C–H?O, C–C?O, and C–H?H. These interactions are further supported by Hirshfeld surface analysis along with 2-D fingerprint plots of complex 2. In vitro DNA-binding studies of both complexes were evaluated using spectroscopic techniques (absorbance and fluorescence) which ascertained optimum binding affinity of both complexes. However, cleavage activity of the complexes was assessed using supercoiled DNA (pBR322) via gel electrophoresis technique which demonstrated significant cleavage pattern of both complexes at different concentrations. Furthermore, chemotherapeutic potential of complexes 1 and 2 against MCF-7 and Hep carcinoma cell lines also suggested significant antiproliferative effect of complexes. These results revealed momentous exploration of drug–DNA interactions which may engender new insinuation for the advancement of metallo-pharmaceuticals.     

Removal of uranium (VI) from nuclear effluents onto aluminophosphate and silicoaluminophosphate molecular sieves

Aluminophosphate and silicoaluminophosphate molecular sieves with both five (AFI) and eleven (AEL) type structures are synthesized by hydrothermal crystallization at 473 K, using tripropylamine and dipropylamine as a structure-directing template. The as-prepared AFI and AEL sieves are characterized and then assessed as sorbents for uranium (VI) from radioactive effluents. The sorption process is used to reduce the volumes of effluents and convert them into a stable solid waste. The batch experimental studies are carried out to evaluate the AEL and AFI structure effect on the removal of uranium. The AlPO₄-5, SAPO-5, AlPO₄-11 and SAPO-11 are applied to radioactive effluents with different activities obtained from Nuclear Research Center of Draria, Algeria. Important decontamination factor values are obtained for AFI sorbents. Thermodynamic parameters, namely, the enthalpy (ΔH), entropy (ΔS) and free energy (ΔG) for each sorption process are calculated. The collected results indicated that sorbents are effective materials for the removal of uranium (VI) ions, the sorbent with AFI structure being a highly effective material for the removal of uranium (VI) ions from nuclear effluents.     

Identification and quantitative analysis of physalin D and its metabolites in rat urine and feces by liquid chromatography with triple quadrupole time‐of‐flight mass spectrometry

Physalin D is known to show extensive bioactivities. However, no excretion study has elucidated the excretion of physalin D and its metabolites. This study investigates the excretion of physalin D and its metabolites in rats. Metabolites in rat urine and feces were separated and identified by liquid chromatography with triple quadrupole time‐of‐flight mass spectrometry. Furthermore, a validated high‐performance liquid chromatography with tandem mass spectrometry method was developed to quantify physalin D, physalin D glucuronide, and physalin D sulfate in rat feces and urine after the intragastric administration of physalin D. The analyte showed good linearity over a wide concentration range (r  > 0.995), and the lower limit of quantification was 0.0532 μg/mL and 0.226 μg/g for urine and feces, respectively. Nine metabolites, including five phase I and four phase II metabolites, were identified and clarified after dosing in vivo. Only 4.0% of the gavaged dose, including physalin D and its phase II metabolites, was excreted in urine, whereas 10.8% was found in feces in the unchanged form. The results indicate that the extensive and rapid metabolism may be the main factors leading to the short half‐life of physalin D. These results can provide a basis for further studies on the structural modification and pharmacology of physalin D.     

A comparative study of HPLC-UV and UPLC-DAD methods for simultaneous estimation of aspirin and cilostazol in the presence of their related impurities in bulk and capsules

Aspirin (ASP) and cilostazol (CST) are used as a combination in pharmaceutical formulations for treatment of strokes. Salicylic acid (SAL) is considered to be one of the main synthesis impurities and a degradation product of ASP. On the other hand, the main related impurities of CST are CST related A, B, and C (CST-RA, CST-RB, and CST-RC), respectively. Furthermore, as high efficiency and less elution are the basic requirements of high-speed chromatographic separation, so, a comparative study of two simple, precise, and accurate reversed-phase HPLC and UPLC methods was developed and validated for simultaneous estimation of ASP and CST in bulk and capsules in the presence of SAL, CST-RA, CST-RB, and CST-RC. A Eurospher II C18 (250?×?4.6?mm², 5?µm) for HPLC method and an Agilent Zorbax Eclipse Plus C18 (50?×?2.1?mm², 1.8?µm) for UPLC method were used. A gradient mobile phase of 20?mM anhydrous KH₂PO₄ buffer solution (containing 0.2% triethylamine (TEA), v/v) with pH adjusted to 2.9 using orthophosphoric acid (solution A) and acetonitrile (solution B) mixed in different proportions for HPLC and UPLC methods was prepared. Flow rate was set to 1.0 and 0.3?mL min^?1 for HPLC and UPLC methods, respectively, and the detection was performed for both methods at 210?nm. It worth noting that the proposed UPLC-DAD assay exhibited relatively much more precision, sensitivity, specificity, and economic and chromatographic separation superiority than proposed HPLC-UV assay. Both developed methods were compared with reference methods to prove its applicability and are suitable for purity assessment of ASP and CST in bulk and capsules.